Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains

Kai Cheng Hsu, Hui Chen Hung, Wei Chun Huangfu, Tzu Ying Sung, Tony Eight Lin, Ming Yu Fang, I. Jung Chen, Nikhil Pathak, John T.A. Hsu, Jinn Moon Yang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Influenza is an annual seasonal epidemic that has continually drawn public attentions, due to the potential death toll and drug resistance. Neuraminidase, which is essential for the spread of influenza virus, has been regarded as a valid target for the treatment of influenza infection. Although neuraminidase drugs have been developed, they are susceptible to drug-resistant mutations in the sialic-binding site. In this study, we established computational models (site-moiety maps) of H1N1 and H5N1 to determine properties of the 150-cavity, which is adjacent to the drug-binding site. The models reveal that hydrogen-bonding interactions with residues R118, D151, and R156 and van der Waals interactions with residues Q136, D151, and T439 are important for identifying 150-cavitiy inhibitors. Based on the models, we discovered three new inhibitors with IC50 values <10 μM that occupies both the 150-cavity and sialic sites. The experimental results identified inhibitors with similar activities against both wild-type and dual H274Y/I222R mutant neuraminidases and showed little cytotoxic effects. Furthermore, we identified three new inhibitors situated at the sialic-binding site with inhibitory effects for normal neuraminidase, but lowered effects for mutant strains. The results suggest that the new inhibitors can be used as a starting point to combat drug-resistant strains.

Original languageEnglish
Article number12336
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Neuraminidase
Saliva
Binding Sites
Pharmaceutical Preparations
Human Influenza
Hydrogen Bonding
Orthomyxoviridae
Drug Resistance
Inhibitory Concentration 50
Mutation
Infection

ASJC Scopus subject areas

  • General

Cite this

Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains. / Hsu, Kai Cheng; Hung, Hui Chen; Huangfu, Wei Chun; Sung, Tzu Ying; Eight Lin, Tony; Fang, Ming Yu; Chen, I. Jung; Pathak, Nikhil; Hsu, John T.A.; Yang, Jinn Moon.

In: Scientific Reports, Vol. 7, No. 1, 12336, 01.12.2017.

Research output: Contribution to journalArticle

Hsu, KC, Hung, HC, Huangfu, WC, Sung, TY, Eight Lin, T, Fang, MY, Chen, IJ, Pathak, N, Hsu, JTA & Yang, JM 2017, 'Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains', Scientific Reports, vol. 7, no. 1, 12336. https://doi.org/10.1038/s41598-017-12101-3
Hsu, Kai Cheng ; Hung, Hui Chen ; Huangfu, Wei Chun ; Sung, Tzu Ying ; Eight Lin, Tony ; Fang, Ming Yu ; Chen, I. Jung ; Pathak, Nikhil ; Hsu, John T.A. ; Yang, Jinn Moon. / Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{64d4c08e639443419580a78040884583,
title = "Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains",
abstract = "Influenza is an annual seasonal epidemic that has continually drawn public attentions, due to the potential death toll and drug resistance. Neuraminidase, which is essential for the spread of influenza virus, has been regarded as a valid target for the treatment of influenza infection. Although neuraminidase drugs have been developed, they are susceptible to drug-resistant mutations in the sialic-binding site. In this study, we established computational models (site-moiety maps) of H1N1 and H5N1 to determine properties of the 150-cavity, which is adjacent to the drug-binding site. The models reveal that hydrogen-bonding interactions with residues R118, D151, and R156 and van der Waals interactions with residues Q136, D151, and T439 are important for identifying 150-cavitiy inhibitors. Based on the models, we discovered three new inhibitors with IC50 values <10 μM that occupies both the 150-cavity and sialic sites. The experimental results identified inhibitors with similar activities against both wild-type and dual H274Y/I222R mutant neuraminidases and showed little cytotoxic effects. Furthermore, we identified three new inhibitors situated at the sialic-binding site with inhibitory effects for normal neuraminidase, but lowered effects for mutant strains. The results suggest that the new inhibitors can be used as a starting point to combat drug-resistant strains.",
author = "Hsu, {Kai Cheng} and Hung, {Hui Chen} and Huangfu, {Wei Chun} and Sung, {Tzu Ying} and {Eight Lin}, Tony and Fang, {Ming Yu} and Chen, {I. Jung} and Nikhil Pathak and Hsu, {John T.A.} and Yang, {Jinn Moon}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-12101-3",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains

AU - Hsu, Kai Cheng

AU - Hung, Hui Chen

AU - Huangfu, Wei Chun

AU - Sung, Tzu Ying

AU - Eight Lin, Tony

AU - Fang, Ming Yu

AU - Chen, I. Jung

AU - Pathak, Nikhil

AU - Hsu, John T.A.

AU - Yang, Jinn Moon

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Influenza is an annual seasonal epidemic that has continually drawn public attentions, due to the potential death toll and drug resistance. Neuraminidase, which is essential for the spread of influenza virus, has been regarded as a valid target for the treatment of influenza infection. Although neuraminidase drugs have been developed, they are susceptible to drug-resistant mutations in the sialic-binding site. In this study, we established computational models (site-moiety maps) of H1N1 and H5N1 to determine properties of the 150-cavity, which is adjacent to the drug-binding site. The models reveal that hydrogen-bonding interactions with residues R118, D151, and R156 and van der Waals interactions with residues Q136, D151, and T439 are important for identifying 150-cavitiy inhibitors. Based on the models, we discovered three new inhibitors with IC50 values <10 μM that occupies both the 150-cavity and sialic sites. The experimental results identified inhibitors with similar activities against both wild-type and dual H274Y/I222R mutant neuraminidases and showed little cytotoxic effects. Furthermore, we identified three new inhibitors situated at the sialic-binding site with inhibitory effects for normal neuraminidase, but lowered effects for mutant strains. The results suggest that the new inhibitors can be used as a starting point to combat drug-resistant strains.

AB - Influenza is an annual seasonal epidemic that has continually drawn public attentions, due to the potential death toll and drug resistance. Neuraminidase, which is essential for the spread of influenza virus, has been regarded as a valid target for the treatment of influenza infection. Although neuraminidase drugs have been developed, they are susceptible to drug-resistant mutations in the sialic-binding site. In this study, we established computational models (site-moiety maps) of H1N1 and H5N1 to determine properties of the 150-cavity, which is adjacent to the drug-binding site. The models reveal that hydrogen-bonding interactions with residues R118, D151, and R156 and van der Waals interactions with residues Q136, D151, and T439 are important for identifying 150-cavitiy inhibitors. Based on the models, we discovered three new inhibitors with IC50 values <10 μM that occupies both the 150-cavity and sialic sites. The experimental results identified inhibitors with similar activities against both wild-type and dual H274Y/I222R mutant neuraminidases and showed little cytotoxic effects. Furthermore, we identified three new inhibitors situated at the sialic-binding site with inhibitory effects for normal neuraminidase, but lowered effects for mutant strains. The results suggest that the new inhibitors can be used as a starting point to combat drug-resistant strains.

UR - http://www.scopus.com/inward/record.url?scp=85030122694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030122694&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-12101-3

DO - 10.1038/s41598-017-12101-3

M3 - Article

AN - SCOPUS:85030122694

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 12336

ER -